Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2024 Aug 21:11:1431639.
doi: 10.3389/fcvm.2024.1431639. eCollection 2024.

Left ventricular outflow tract obstruction after transcatheter mitral valve replacement: a case report with a multifaceted approach

Affiliations
Case Reports

Left ventricular outflow tract obstruction after transcatheter mitral valve replacement: a case report with a multifaceted approach

Berenice Caneiro-Queija et al. Front Cardiovasc Med. .

Abstract

An 83-year-old woman was admitted to our center because of heart failure. Transthoracic echocardiography revealed severe mitral annular calcification resulting in a double mitral valve lesion. After discussion by the heart team, transcatheter mitral valve replacement with Tendyne (Abbott Structural, Santa Clara, CA, USA) was performed. Despite having a predicted neo-left ventricular outflow tract (LVOT) above the cut-off value, the patient developed clinically significant LVOT obstruction (LVOTO) refractory to medical treatment. This situation is often treated before the intervention, and dealing with LVOTO afterward can be challenging. After taking the patient's anatomy into consideration, we decided to perform alcohol septal ablation. Applying a combined strategy of medical treatment and intervention led to success. In this case report, we discuss this event and the strategies available for preventing and managing the condition.

Keywords: Tendyne; alcohol septal ablation (ASA); left ventricular outflow tract obstruction; mitral annular calcification; transcatheter mitral valve replacement.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Patient timeline.

References

    1. Iung B, Delgado V, Rosenhek R, Price S, Prendergast B, Wendler O, et al. Contemporary presentation and management of valvular heart disease: the EURObservational research programme valvular heart disease II survey. Circulation. (2019) 140(14):1156–69. 10.1161/CIRCULATIONAHA.119.041080 - DOI - PubMed
    1. Van Hemelrijck M, Taramasso M, Gülmez G, Maisano F, Mestres CA. Mitral annular calcification: challenges and future perspectives. Indian J Thorac Cardiovasc Surg. (2020) 36(4):397–403. 10.1007/s12055-019-00910-2 - DOI - PMC - PubMed
    1. Abramowitz Y, Jilaihawi H, Chakravarty T, Mack MJ, Makkar RR. Mitral annulus calcification. J Am Coll Cardiol. (2015) 66(17):1934–41. 10.1016/j.jacc.2015.08.872 - DOI - PubMed
    1. Sorajja P, Gössl M, Babaliaros V, Rizik D, Conradi L, Bae R, et al. Novel transcatheter mitral valve prosthesis for patients with severe mitral annular calcification. J Am Coll Cardiol. (2019) 74(11):1431–40. 10.1016/j.jacc.2019.07.069 - DOI - PubMed
    1. Agrawal A, Reardon MJ, Goel SS. Transcatheter mitral valve replacement in patients with mitral annular calcification: a review. Heart Int. (2023) 17(1):19–26. 10.17925/HI.2023.17.1.19 - DOI - PMC - PubMed

Publication types

LinkOut - more resources